Association between SGLT2 inhibitors vs DPP4 inhibitors and renal outcomes among patients with type 2 diabetes
Au PCM, Tan KCB, Cheung BMY, et al.
J Clin Endocrinol Metab. 2022;107(7):e2962-e2970.
Leggi
Breaking news
Precision prognostics for the development of complications in diabetes
Schiborn C, Schulze MB
Diabetologia. Pub. online 21 Jun 2022.
Leggi
Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial
Messer LH, Buckingham BA, Cogen F, et al.
Diabetes Technol Ther. Pub. online 28 Jun 2022.
Leggi
Real World Evidence Supporting Tandem Control-IQ Hybrid Closed Loop Success in the Medicare and Medicaid Type 1 and Type 2 Diabetes Populations
Forlenza GP, Carlson AL, Galindo R et al
Diabetes Technol Ther. Pub. online 28 Jun 2022.
Leggi
Clinical predictors for nondiabetic kidney diseases in patients with type 2 diabetes mellitus: a retrospective study from 2017 to 2021
Zeng Y, Yang Y, Guan CJ, et al.
BMC Endocr Disord. 2022;22(1):168
Leggi
Essential CGM metrics: the principal dimensions of glycemic control in diabetes
Montaser E, Fabris C, Kovatchev BP
Diabetes Technol Ther. Pub. online 17 Jun 2022
Leggi
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled
Ferreira JP, Zannad F, Butler J, et al.
Eur Heart J. 2022;ehac306.
Leggi
Evaluation of clinical metrics for identifying defective physiologic responses to hypoglycemia in long-standing type 1 diabetes
Flatt AJ, Chen E, Peleckis AJ, et al.
Diabetes Technol Ther. Pub. online 27 Jun 2022.
Leggi
A systematic review supporting the Endocrine Society clinical practice guideline for the management of hyperglycemia in adults hospitalized for noncritical illness or undergoing elective surgical procedures
O Seisa M, Saadi S, Nayfeh T, et al.
J Clin Endocrinol Metab. 2022;dgac277
Leggi
Obesity in late adolescence and incident type 1 diabetes in young adulthood
Zucker I, Zloof Y, Bardugo A, et al.
Diabetologia. Pub. online 5 Jun 2022.
Leggi